Results 31 to 40 of about 466,490 (234)

Hepatitis A Screening and Vaccination Among People Living with HIV: When is the Ideal Time?

open access: yesMediterranean Journal of Infection, Microbes and Antimicrobials
Introduction: This study aimed to determine the hepatitis A seroprevalence and vaccination status among [people living with Human Immunodeficiency Virus (HIV) (PLWH)], assess serologic responses to vaccination, and identify age groups for which hepatitis
Meltem Ceylan   +6 more
doaj   +1 more source

Changes in hepatitis A virus (HAV) seroprevalence in medical students in Bangkok, Thailand, from 1981 to 2016

open access: yesBMC Research Notes, 2018
Objective This study aimed to determine the seroprevalence of anti-HAV IgG in Thai medical students in 2016 compared with the previous data and to demonstrate the cross-effective strategy to screen HAV seropositivity.
Palittiya Sintusek   +5 more
doaj   +1 more source

Risque professionnel d'hépatite virale A au contact des eaux usées [PDF]

open access: yes, 1995
La disponibilité depuis 1992 d'un premier vaccin contre l'hépatite virale A a soulevé la question de son indication chez le personnel exposé aux eaux usées.
Roudot-Thorval, F., Schlosser, O.
core   +1 more source

Vectorial entry and release of hepatitis a virus in polarized human hepatocytes [PDF]

open access: yes, 2008
Hepatitis A virus (HAV) is an enterically transmitted virus that replicates predominantly in hepatocytes within the liver before excretion via bile through feces.
Snooks, Michelle J.   +5 more
core   +2 more sources

Suppression of La antigen exerts potential antiviral effects against hepatitis A virus.

open access: yesPLoS ONE, 2014
BackgroundDespite the development and availability of hepatitis A virus (HAV) vaccine, HAV infection is still a major cause of acute hepatitis that occasionally leads to fatal liver disease.
Xia Jiang   +10 more
doaj   +1 more source

The interaction of hepatitis A virus (HAV) with soluble forms of its cellular receptor 1 (HAVCR1) share the physiological requirements of infectivity in cell culture

open access: yesVirology Journal, 2009
Background Hepatitis A virus (HAV), an atypical Picornaviridae that causes acute hepatitis in humans, usurps the HAV cellular receptor 1 (HAVCR1) to infect cells. HAVCR1 is a class 1 integral membrane glycoprotein that contains two extracellular domains:
Kaplan Gerardo G   +2 more
doaj   +1 more source

Quantitative Risk Assessment of Hepatitis a Virus Infection Arising from the Consumption of Fermented Clams in South Korea

open access: yesFoods, 2023
This study estimated the risk of hepatitis A virus (HAV) foodborne illness outbreaks through the consumption of fermented clams in South Korea. HAV prevalence in fermented clams was obtained from the Ministry of Food and Drug Safety Report, 2019 ...
Yoonjeong Yoo   +6 more
doaj   +1 more source

From Policy to Practice: A Global Review of Circular Economy Strategy Documents in Construction Using NLP

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT This study explores how circular economy (CE) principles are incorporated in construction‐related policy roadmaps worldwide, addressing the growing need for effective resource strategies in a highly material‐intensive sector. National strategic CE documents from 57 countries were analyzed using natural language processing techniques, and then ...
Aidana Tleuken   +5 more
wiley   +1 more source

Seroprevalence of hepatitis A virus antibodies among children and adolescents living in Northern Thailand: an implication for hepatitis A immunization

open access: yesScientific Reports, 2023
This cross-sectional study aimed to assess seroprevalence of hepatitis A virus (HAV) antibodies and identify factors associated with HAV seropositivity among children and adolescents aged 1–18 years who resided in Chiang Mai, Thailand.
Natchaya Kunanitthaworn   +7 more
doaj   +1 more source

Antibodies to hepatitis A virus in Italian patients with chronic liver disease [PDF]

open access: yes, 2001
To improve our knowledge for future hepatitis A virus (HAV) vaccination strategies we carried out a multicentre study on naturally acquired immunological protection against HAV in patients with chronic hepatitis in Italy.
Sagnelli, Evangelista   +11 more
core  

Home - About - Disclaimer - Privacy